hiv

Which HIV Treatment is Best for Patients with HIV and Hepatitis C?+

23rd September 2007
Juan Berenguer
juan berenguer Which HIV Treatment is Best for Patients with HIV and Hepatitis C?
Juan Berenguer

REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JUAN BERENGUER, Hospital Gregorio Marañón, Madrid
A retrospective study has thrown doubt on the theory that protease inhibitors (PIs) are a preferable antiretroviral

…

Read More+

Entecavir for Hepatitis B Linked to HIV Resistance+

20th September 2007
Moira McMahon
moira mcmahon Entecavir for Hepatitis B Linked to HIV Resistance
Moira McMahon

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
MOIRA MCMAHON, Johns Hopkins University, Baltimore
The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for

…

Read More+

Monoclonal Antibody to Help Treat HIV?+

20th September 2007
Jeffrey Jacobson
jeffrey jacobson Monoclonal Antibody to Help Treat HIV?
Jeffrey Jacobson

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia
Could a monoclonal antibody have a role to play in HIV treatment? Early data on the PRO 140

…

Read More+

Maraviroc for HIV: Responses at 48 Weeks+

20th September 2007
jacob lalezari Maraviroc for HIV: Responses at 48 Weeks
Jacob Lalezari

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JACOB LALEZARI, Quest Clinical Research, San Francisco
Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of

…

Read More+

London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007+

31st August 2007
philippe mayaud London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007
Philippe Mayaud

Herpes Simplex Therapy Reduces HIV Activity in Co-Infected Patients

REFERENCE: N Engl J Med 2007; 356: 790-9
PHILIPPE MAYAUD, London School of Hygiene and Tropical Medicine
It is possible to reduce HIV activity in patients who are co-infected

…

Read More+

London School of Hygiene & Tropical Medicine Audio News Review, August 28th, 2007+

30th August 2007
pat doyle London School of Hygiene & Tropical Medicine Audio News Review, August 28th, 2007
Pat Doyle

Increased Miscarriage Risk in Women with Low Body Mass Index

REFERENCE: BJOG 2007 114:170
PAT DOYLE, London School of Hygiene and Tropical Medicine
Underweight women with a BMI below 18.5 have a 70 per cent increase in their

…

Read More+

London School of Hygiene & Tropical Medicine Audio News+

16th August 2007
simon lewin London School of Hygiene & Tropical Medicine Audio News
Simon Lewin

Adherence to TB Medication

PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238
SIMON LEWIN, London School of Hygiene and Tropical Medicine
A new systematic review has shown that we don’t understand well enough the reasons for poor adherence to tuberculosis medication. Simon

…

Read More+

Pneumonia in Children Under One Year: Current Guidelines Not Sufficient+

28th May 2007
lisa mcnally Pneumonia in Children Under One Year: Current Guidelines Not Sufficient

LISA McNALLY, Institute of Child Health, London, and University of KwaZulu-Natal, Durban

REFERENCE: The Lancet 2007; 369:1440-1451
A new study suggests that current guidelines for the treatment of severe pneumonia in children under one year should change. The investigation, which took place …
Read More+

Non-Perfect HIV Vaccine Could Still Have Major Benefits+

25th May 2007
anthony fauci Non Perfect HIV Vaccine Could Still Have Major Benefits

ANTHONY FAUCI, National Institutes of Health, Bethesda

REFERENCE: N Engl J Med 2007;356:2073-81
Is there any hope for an HIV vaccine? According to Anthony Fauci, of the National Institutes of Health in Bethesda, there is – but it might …
Read More+

Once-And-For-All TB Assay Brings Cheap, Sensitive, Specific, Seven-Day Diagnosis and Drug-Susceptibility Testing+

15th April 2007
david moore Once And For All TB Assay Brings Cheap, Sensitive, Specific, Seven Day Diagnosis and Drug Susceptibility Testing

DAVID MOORE, Imperial College, London and Lima

REFERENCE: N Engl J Med 355: 1539-50
A new test for TB, trialled in Peru, has proved more powerful and yet faster and cheaper than alternatives, making it especially suitable for use in …
Read More+

6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates+

15th March 2007
hoosen coovadia 120 6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates

HOOSEN COOVADIA, University of KwaZulu-Natal, Durban

REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
In the developing world breastfeeding is the recommended infant feeding method, even for women infected with HIV. While early …
Read More+

Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety+

13th March 2007
howard mayer Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety

mark wainberg Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety

HOWARD MAYER, Pfizer Global Research, New London CT
MARK WAINBERG, McGill University, Montreal

Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
In a population of treatment-experienced HIV-infected subjects, maraviroc plus optimised background …
Read More+